Skip to main content [accesskey + 1] Skip to navigation [accesskey + 2] Skip to sidebar [accesskey + 3]


Local Servicelinks



Search our news in a chronological order.


DRKS Now with its own Newsletter

Feb 1, 2018

From now on, you can subscribe to our free newsletter with reports on the German Clinical Trials Register (DRKS) and other related topics.

The DRKS provides information on both ongoing and completed clinical trials in Germany. For each study, we provide key data such as study titles, brief descriptions, criteria for inclusion and exclusion in the study, the study status and endpoints.

DRKS is recognised by WHO (World Health Organisation) as primary registry for Germany. By registering your own studies, you not only make them accessible to others but also meet the requirements of renowned medical journals for publication.

The registry’s aim is to provide the public with a complete and up-to-date overview of clinical trials conducted in Germany as a central point of reference.

The DRKS not only serves as a source of information for patients. It also supports professionals in planning clinical trials, for example, by helping to avoid duplicate studies.

Subscribe to the Newsletter

Simply subscribe to the newsletter via the button "Subscribe to the Newsletter" on our news overview page at: - News. The newsletter provides you with latest reports on the German Clinical Trials Register (DRKS) and other related topics of DIMDI.

Further Information at DIMDI:
External Information: